Dr. Roland Skeel, MD
Claim this profileUniversity of Toledo
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
18 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage III
Stage I
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Roland Skeel, MD is currently running
Zotatifin
for Solid Tumors
This trial is testing a new drug called Zotatifin for patients with advanced cancers that haven't improved with standard treatments. The drug works by stopping cancer cells from making essential proteins, which may slow or stop the cancer.
Recruiting3 awards Phase 1 & 221 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Roland Skeel, MD
Clinical Trial Related11 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Roland Skeel, MD has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- EFT226
- ZX-101A
- Biospecimen Collection
Breakdown of trials Roland Skeel, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roland Skeel, MD specialize in?
Roland Skeel, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Roland Skeel, MD currently recruiting for clinical trials?
Yes, Roland Skeel, MD is currently recruiting for 3 clinical trials in Toledo Ohio. If you're interested in participating, you should apply.
Are there any treatments that Roland Skeel, MD has studied deeply?
Yes, Roland Skeel, MD has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Roland Skeel, MD?
Apply for one of the trials that Roland Skeel, MD is conducting.
What is the office address of Roland Skeel, MD?
The office of Roland Skeel, MD is located at: University of Toledo, Toledo, Ohio 43614 United States. This is the address for their practice at the University of Toledo.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.